Home/Filings/4/0001310204-25-000011
4//SEC Filing

Dickinson Andrew D 4

Accession 0001310204-25-000011

CIK 0000882095other

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 5:12 PM ET

Size

4.8 KB

Accession

0001310204-25-000011

Insider Transaction Report

Form 4
Period: 2025-09-15
Dickinson Andrew D
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-09-15$113.57/sh2,500$283,925159,555 total
Footnotes (1)
  • [F1]The transaction reported in the this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.

Issuer

GILEAD SCIENCES, INC.

CIK 0000882095

Entity typeother

Related Parties

1
  • filerCIK 0001310204

Filing Metadata

Form type
4
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 5:12 PM ET
Size
4.8 KB